Latest profit margin for Lilly(Eli): 31.86% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
Lilly(Eli) (LLY) currently reports a profit margin of 31.86% as of September 2026. That compares with 30.99% in the prior-year period — up 2.8% year over year. That is above the Healthcare sector average of 19.13%. Use the charts on this page to explore Lilly(Eli)'s profit margin history and peer comparisons.
Lilly(Eli)'s profit margin increased from 30.99% to 31.86% — a 2.8% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Lilly(Eli)'s profit margin of 31.86% is higher than the Healthcare sector average of 19.13%. That is roughly 66.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Lilly(Eli)'s current 31.86% should be judged against Healthcare norms (sector average: 19.13%) and against LLY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 31.86%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 19.13%. From there, open related valuation or income-statement pages for Lilly(Eli), and consider following LLY for alerts when major investors trade the stock.